Multicenter retrospective and prospective analysis of emicizumab and FVIII prophylaxis in children with severe hemophilia A

被引：0
|
作者：
Hassan, Tamer [1 ]
Lotfy, Gehan [2 ]
Elalfy, Omar [3 ]
Amin, Mervat [4 ]
Elmasry, Zahraa [5 ]
Elhawary, Eslam [6 ]
Darwish, Ahmed [7 ]
Elalfy, Mohsen [8 ]
机构：
[1] Zagazig Univ, Dept Pediat, Zagazig, Egypt
[2] Menia Univ, Menia, Egypt
[3] Natl Res Ctr, Complementary Med Dept, Cairo, Egypt
[4] Assiut Univ, Assiut, Egypt
[5] Sohag Univ, Sohag, Egypt
[6] Tanta Univ, Tanta, Egypt
[7] Mansoura Univ, Mansoura, Egypt
[8] Ain Shams Univ, Cairo, Egypt
来源：
HAEMOPHILIA | 2024年 / 30卷
关键词：
Hemophilia A; Factor VIII; Emicizumab;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
LBA-PP-004
引用
收藏
页码：222 / 223
页数：2
相关论文
共 50 条
  • [31] HIV positive patient with severe hemophilia A and malignant lymphoma: prophylaxis with recombinant fviii
    Geierova, V
    Pohlreichova, V
    Rittich, S.
    Benesova, K.
    Hrachovinova, I., V
    Cetkovsky, P.
    Salaj, P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 516 - 516
  • [32] Prevention of Bleeding in Patients with Moderate and Severe Hemophilia A Playing Sports: A Comparison between Factor VIII and Emicizumab Prophylaxis (STEP: SporTs Emicizumab Prophylaxis)
    Chitlur, Meera B.
    BLOOD, 2022, 140 : 5619 - 5620
  • [33] ECONOMIC EVALUATION OF IMMUNE TOLERANCE INDUCTION FOR CHILDREN WITH SEVERE HEMOPHILIA A AND HIGH-RESPONDING INHIBITORS: A COST-EFFECTIVENESS ANALYSIS OF PROPHYLAXIS WITH EMICIZUMAB
    Camelo, R.
    Barbosa, M. M.
    Araujo, M. S.
    Muniz Junior, R. L.
    Guerra Junior, A. A.
    Godman, B.
    Rezende, S. M.
    Acurcio, F. D. A.
    Martin, A. P.
    Alvares-Teodoro, J.
    HAEMOPHILIA, 2023, 29 : 52 - 52
  • [34] Emicizumab prophylaxis in a Korean child with severe hemophilia A and high titer inhibitor: a case report
    Ahn, Ji Hyun
    Jung, Nani
    Shim, Ye Jee
    Kim, Heung Sik
    BLOOD RESEARCH, 2021, 56 (01) : 44 - 46
  • [35] The impact of prophylaxis on children with severe hemophilia.
    Panicker, J
    Warrier, I
    Lusher, JM
    Thomas, R
    BLOOD, 2001, 98 (11) : 531A - 531A
  • [36] Economic Evaluation of Immune Tolerance Induction in Children With Severe Hemophilia A and High-Responding Inhibitors: A Cost-Effectiveness Analysis of Prophylaxis With Emicizumab
    Camelo, Ricardo Mesquita
    Barbosa, Mariana Michel
    Araujo, Maiara Silva
    Muniz, Roberto Lucio, Jr.
    Guerra, Augusto Afonso, Jr.
    Godman, Brian
    Rezende, Suely Meireles
    Acurcio, Francisco de Assis
    Martin, Antony P.
    Alvares-Teodoro, Juliana
    VALUE IN HEALTH REGIONAL ISSUES, 2023, 34 : 31 - 39
  • [37] RESULTS OF SECONDARY PROPHYLAXIS IN CHILDREN WITH SEVERE HEMOPHILIA
    MANCOJOHNSON, MJ
    NUSS, R
    GERAGHTY, S
    FUNK, S
    KILCOYNE, R
    AMERICAN JOURNAL OF HEMATOLOGY, 1994, 47 (02) : 113 - 117
  • [38] EQUITY IN THE USE OF PROPHYLAXIS IN CHILDREN WITH SEVERE HEMOPHILIA
    Tootoonchian, E.
    Stonebraker, J.
    El Ekiaby, M.
    Gouider, E.
    Iorio, A.
    Makris, M.
    O'Hara, J.
    Recht, M.
    Pierce, G.
    Coffin, D.
    HAEMOPHILIA, 2021, 27 : 20 - 20
  • [39] PROPHYLAXIS WITH EMICIZUMAB IN 8 CHILDREN WITH HEMOPHILIA A AND INHIBITORS: REAL-WORLD DATA OF A PORTUGUESE HEMOPHILIA CENTER
    Catarino, C.
    Campanico, S.
    Rodrigues, F.
    Pereira, A.
    HAEMOPHILIA, 2020, 26 : 70 - 70
  • [40] Efanesoctocog Alfa Prophylaxis for Children with Severe Hemophilia A
    Malec, Lynn
    Peyvandi, Flora
    Chan, Anthony K. C.
    Koenigs, Christoph
    Zulfikar, Bulent
    Yuan, Huixing
    Simpson, Mindy
    Roman, Maria Teresa Alvarez
    Carcao, Manuel
    Staber, Janice M.
    Dunn, Amy L.
    Chou, Sheng-Chieh
    d'Oiron, Roseline
    Albisetti, Manuela
    Demissie, Marek
    Santagostino, Elena
    Yarramaneni, Abhimanyu
    Wong, Nancy
    Abad-Franch, Lydia
    Gunawardena, Sriya
    Fijnvandraat, Karin
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (03): : 235 - 246
12345